LYRA
Lyra Therapeutics, Inc.Company with tickers: LYRA
CIK
1327273
CUSIP
55234L204
Shares Outstanding
1,774,882
13F Activity (30d)
3 filings
2 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-14 | Smith W Bradford |
See remarks | Other | 640 |
| 2026-04-01 | Cavalier Jason |
Principal Financial Officer | Other | 667 |
| 2026-04-01 | Palasis Maria |
Director, Principal Executive Officer | Other | 2,000 |
| 2026-01-06 | Palasis Maria |
Director, Principal Executive Officer | Sell | 1,702 |
| 2026-01-06 | Cavalier Jason |
Principal Financial Officer | Sell | 769 |
| 2025-11-13 | PERCEPTIVE ADVISORS LLC |
10% Owner | Sell | 3,213 |
| 2025-11-13 | PERCEPTIVE ADVISORS LLC |
10% Owner | Sell | 28,597 |
| 2025-11-12 | PERCEPTIVE ADVISORS LLC |
10% Owner | Sell | 7,862 |
| 2025-11-12 | PERCEPTIVE ADVISORS LLC |
10% Owner | Sell | 883 |
| 2025-11-11 | PERCEPTIVE ADVISORS LLC |
10% Owner | Sell | 4,783 |
| 2025-11-11 | PERCEPTIVE ADVISORS LLC |
10% Owner | Sell | 537 |
| 2025-11-10 | PERCEPTIVE ADVISORS LLC |
10% Owner | Sell | 16,633 |
| 2025-11-10 | PERCEPTIVE ADVISORS LLC |
10% Owner | Sell | 1,869 |
| 2025-11-07 | PERCEPTIVE ADVISORS LLC |
10% Owner | Sell | 17,746 |
| 2025-11-07 | PERCEPTIVE ADVISORS LLC |
10% Owner | Sell | 1,993 |
| 2025-11-06 | PERCEPTIVE ADVISORS LLC |
10% Owner | Sell | 3,247 |
| 2025-11-06 | PERCEPTIVE ADVISORS LLC |
10% Owner | Sell | 28,902 |
| 2025-10-01 | Palasis Maria |
Director, Principal Executive Officer | Award | 3,667 |
| 2025-07-10 | Cavalier Jason |
Principal Financial Officer | Sell | 684 |
| 2025-07-10 | Palasis Maria |
Director, Principal Executive Officer | Sell | 1,565 |
| 2025-05-14 | TOBIN JAMES R |
Director | Award | 32,000 |
| 2025-05-14 | MERRIFIELD C ANN |
Director | Award | 32,000 |
| 2025-05-14 | snyderman nancy lynn MD |
Director | Award | 32,000 |
| 2025-05-14 | Smith W Bradford |
See remarks | Award | 32,000 |
| 2025-01-08 | Palasis Maria |
Director, Principal Executive Officer | Award | 800,000 |
| 2025-01-08 | Cavalier Jason |
Principal Financial Officer | Award | 420,000 |
| 2024-12-09 | Palasis Maria |
Director, Principal Executive Officer | Award | 183,333 |
| 2024-12-09 | Waksal Harlan |
Director | Award | 128,333 |
| 2024-10-16 | Palasis Maria |
Director, Principal Executive Officer | Award | 300,000 |
| 2024-10-16 | Cavalier Jason |
Principal Financial Officer | Award | 100,000 |
| 2024-06-13 | MERRIFIELD C ANN |
Director | Award | 30,000 |
| 2024-06-13 | Smith W Bradford |
See remarks | Award | 30,000 |
| 2024-06-13 | Poukalov Konstantin |
Director | Award | 30,000 |
| 2024-06-13 | TOBIN JAMES R |
Director | Award | 30,000 |
| 2024-06-13 | snyderman nancy lynn MD |
Director | Award | 30,000 |
| 2024-06-13 | ALTMAN MICHAEL SETH |
Director, Chief Business Officer, 10% Owner | Award | 30,000 |
| 2024-03-18 | Waksal Harlan |
Director | Award | 275,000 |
| 2024-03-18 | Palasis Maria |
Director, Principal Executive Officer | Award | 500,000 |
| 2024-01-30 | Bishop John E |
Chief Technology Officer | Award | 200,000 |
| 2024-01-30 | Nieman Richard |
Chief Medical Officer | Award | 200,000 |
| 2024-01-30 | Cavalier Jason |
Principal Financial Officer | Award | 200,000 |
| 2023-11-10 | Waksal Harlan |
Director | Buy | 25,000 |
| 2023-06-30 | snyderman nancy lynn MD |
Director | Award | 20,000 |
| 2023-06-30 | ALTMAN MICHAEL SETH |
Director, Chief Business Officer, 10% Owner | Award | 20,000 |
| 2023-06-30 | Smith W Bradford |
See remarks | Award | 20,000 |
| 2023-06-30 | TOBIN JAMES R |
Director | Award | 20,000 |
| 2023-06-30 | Poukalov Konstantin |
Director | Award | 20,000 |
| 2023-06-30 | MERRIFIELD C ANN |
Director | Award | 20,000 |
| 2023-06-30 | ANDERSON EDWARD T |
Director, 10% Owner | Award | 20,000 |
| 2023-06-15 | Palasis Maria |
Director, Principal Executive Officer | Award | 150,000 |
Showing 1–50 of 425 transactions